Drug intelligence / Profile preview

local anesthetic + epinephrine + morphine + Surgicel

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

A combination of local anesthetic, epinephrine, morphine, and Surgicel used in surgical procedures. The local anesthetic (commonly bupivacaine or lidocaine) provides pain control, epinephrine extends the duration of anesthesia and reduces bleeding through vasoconstriction, morphine offers extended postoperative analgesia, and Surgicel serves as a hemostatic agent to control bleeding. This combination is used to provide preemptive analgesia, reduce blood loss, and decrease the need for rescue narcotics in the postoperative period.

Targets

AR (Adrenergic receptors)NaV (Voltage-gated sodium channels)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on local anesthetic + epinephrine + morphine + Surgicel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on local anesthetic + epinephrine + morphine + Surgicel.

Explore the full profile